United States Hepatitis C Treatment Market Set for Strong Growth with Breakthrough Therapies and Expanding Patient Access 2025 | Major key players - AbbVie Inc., Merck & Co., Inc., Gilead Sciences, Inc.

Market Overview:

The Hepatitis C Treatment Market is expected to reach at a CAGR of 13.5% during the forecast period (2024-2031).

The Hepatitis C Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/hepatitis-c-treatment-market?sz

The Hepatitis C Treatment Market encompasses therapies, drugs, and innovative approaches aimed at curing or managing Hepatitis C virus (HCV) infection. It includes direct-acting antivirals, combination therapies, and supportive treatments designed to eliminate the virus, reduce liver damage, and improve patient outcomes. Market growth is driven by rising prevalence, advancements in drug development, and increased awareness programs.

Recent Key Developments of United States (U.S):

Expanded FDA Approval for MAVYRET: On June 11, 2025, the FDA approved AbbVie's MAVYRET (glecaprevir/pibrentasvir) for an expanded indication. It is now the first and only eight-week, pan-genotypic treatment approved for people with acute Hepatitis C virus (HCV), in addition to its existing approval for chronic HCV.

Growing "Test and Treat" Models: The expanded MAVYRET approval facilitates "test and treat" models of care, allowing healthcare providers to initiate treatment immediately upon diagnosis, which is a key strategy to simplify care pathways and accelerate the goal of disease elimination.

Continued Dominance of DAAs: Direct-acting antivirals (DAAs) remain the primary treatment option, with high efficacy and shorter treatment durations compared to older therapies.

Focus on Affordability and Accessibility: While the US market leads in revenue, a major trend is the focus on making treatments more accessible and affordable. This includes the availability of generics and strategic efforts by companies and government initiatives to reduce costs.

Improved Patient Access: Major insurance providers in the US expanded coverage for new hepatitis C treatments in August 2025, which is helping to improve patient access nationwide.

List of the Key Players in the Hepatitis C Treatment Market:

AbbVie Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
Genentech, Inc.
Kadmon Pharmaceuticals, LLC
Cipla Ltd
Mylan Laboratories Limited
Strides Arcolab Limited.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=hepatitis-c-treatment-market

Segments Covered in the Hepatitis C Treatment Market:

By Drug Class: HCV Protease Inhibitors, HCV Polymerase Inhibitors, Combination Therapy, Interferon, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hepatitis-c-treatment-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Hepatitis C Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Hepatitis C Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Hepatitis C Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Hepatitis C Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Hepatitis C Treatment Market in 2025?
◆ What is the projected growth rate of the Hepatitis C Treatment Market through 2033?
◆ Who are the key players in the Hepatitis C Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.